What is IPO Grey Market Premium (GMP)?

IPO Grey Market Premium (GMP) is an unofficial, over-the-counter premium over the issue price that dealers and investors pay prior to official listing on NSE/BSE.

How is estimated IPO listing price determined?

Estimated Listing Price = Cut-off / Issue Price + Current Grey Market Premium (GMP). For example, an issue price of ₹100 with ₹40 GMP yields an estimated listing price of ₹140 (+40%).

What is Kostak rate in an IPO?

Kostak rate is the fixed profit earned by selling an IPO application before allotment, irrespective of whether the application is allotted shares or not.

What is Subject to Sauda in IPO trading?

Subject to Sauda is an informal contract where payment is made only if the seller receives share allotment in the IPO.

Is IPO Grey Market Premium (GMP) regulated by SEBI?

No. Grey Market transactions are non-exchange over-the-counter commitments and are not officially regulated or endorsed by SEBI. Investors should treat GMP as an informal sentiment indicator.

What is the current subscription status of Biopol Chemicals Limited IPO?

Biopol Chemicals Limited IPO has received a total subscription of 22.39 times overall.

IPO GreyPremiumLIVE

Grey Market Intelligence

Biopol Chemicals Limited

ListedSME

Chemicals · NSE

Incorporated in 2023, Biopol Chemicals Limited manufactures and supplies specialty chemicals such as silicones, emulsifiers, biochemicals, and polyelectrolytes, with a total product range of 66 items used across industries like textiles, home care, agriculture, and industrial chemicals. The company follows a B2B model and serves institutional clients only. It operates four establishments located in Gujarat and West Bengal, including a manufacturing unit, corporate office, and warehouse in West Bengal, along with a registered office in Gujarat, with a total installed manufacturing capacity of 18,25,000 litres per year. As of December 31, 2025, the company had a workforce of 24 employees.

Price Band

₹102 – ₹108

Issue Size

₹31.25 Cr

Lot Size

1200 shares

GMP

₹2

+1.9%

Est. Listing

₹110

at current GMP

Subscribed

22.39x

overall

Open

6 Feb 2026

10 Feb 2026

Allotment

11 Feb 2026

Refund

12 Feb 2026

Demat Credit

13 Feb 2026

Listing

13 Feb 2026

Last updated 12 days ago

Overview Live GMP Subscription Status Allotment Status Filing Documents

Overall Subscription

22.39x

Total Demand

QIB Multiplier

21.05x

Institutions & Funds

NII / HNI

24.62x

High Net-Worth

Retail (RII)

20.80x

Individual Bidders

Category-Wise Subscription Breakup

Live bidding breakdown by institutional, non-institutional, and retail investors

Total 22.39x

Category	Shares Offered	Shares Applied / Bid	Times Subscribed
QIB	686,400	14,449,200	21.05x
NIB	1,094,400	26,948,400	24.62x
HNIs(10L +)	729,600	20,205,600	27.69x
HNIs (2-10L)	364,800	6,742,800	18.48x
RETAIL	962,400	20,018,400	20.80x
Total	3,837,600	88,364,400	22.39x

Application-Wise Breakup

Total unique applications received across retail and HNI tranches

Apps 19.14x

Category	Applications Reserved	Applications Received	Times Subscribed
QIB	—	17	0.00x
NIB	—	3,918	0.00x
RETAIL	481	8,341	17.34x
HNIs(10L +)	243	2,070	8.52x
HNIs (2-10L)	122	1,848	15.15x
Total Applications	846	16,194	19.14x

Day-Wise Subscription Progress

Track continuous institutional and retail bidding order books for all active issues on the ipo live subscription feed.

About Biopol Chemicals Limited Public Issue & Market Profile

Biopol Chemicals Limited is bringing an initial public offering (IPO) in the Chemicals sector with an aggregate issue size of ₹31.25 Crores. The shares are offered at a price band of ₹102 to ₹108 per equity share on NSE. Currently, investors are tracking the grey market premium (GMP) and institutional subscription multiples closely across BSE and NSE portals.

Bidding & Quota Instructions:

The public offer consists of a fresh issue and offer-for-sale structured under SEBI regulations. Bidding is open to Qualified Institutional Buyers (QIB), Non-Institutional Bidders (NII/HNI), and Retail Individual Investors (RII). Applications can be submitted online using ASBA or UPI mandate through certified stock brokers and net banking portals.

Allotment Reconciliation Schedule:

Following the close of bidding on 2026-02-10, the basis of allotment is scheduled to be finalized on 2026-02-11. Investors can verify their application status online by submitting their PAN card number, Application Number, or DP Client ID on the registrar's official portal (Bigshare Services Private Limited) or the BSE allotment checking window.

Frequently Asked Questions

What is Biopol Chemicals Limited IPO GMP today?

The latest Grey Market Premium (GMP) for Biopol Chemicals Limited IPO is ₹2 per equity share. Based on the upper price band of ₹102 to ₹108 per equity share, the estimated listing price is ₹110 (+1.9% expected listing gain).

What is the expected profit per lot for Biopol Chemicals Limited IPO?

With a lot size of 1200 shares and current GMP of ₹2, the expected profit per application lot is approx ₹2,400 (+1.9% gain). Minimum application cost is approx ₹1,29,600.

What is the issue size and price band for Biopol Chemicals Limited IPO?

The Biopol Chemicals Limited IPO aggregate issue size is ₹31.25 Crores with an equity price band set at ₹102 to ₹108 per equity share. The retail lot size is 1200 shares requiring a minimum capital outlay of approx. ₹1,29,600.

How can I check Biopol Chemicals Limited IPO live subscription demand?

Live subscription figures are compiled real-time from the NSE and BSE bidding engines. Currently, overall subscription is 22.39x (Retail: 20.80x, QIB: 21.05x, NII: 24.62x). You can track live multiples directly on our dedicated subscription page.

Where and when will Biopol Chemicals Limited IPO allotment status be published?

The basis of allotment will be published on the official registrar portal (Bigshare Services Private Limited) and the BSE status verification website on or around 2026-02-11. Investors can verify status using PAN card or application number.

When is the listing date for Biopol Chemicals Limited IPO?

Biopol Chemicals Limited shares are scheduled to list on NSE on 2026-02-13.